Crystallisation of form II, form III or forms II + III (concomitant) carbamazepine by varying nucleant surface chemistry and solute concentration.
No takes yet. Share an insight, caveat, or question.
Parambil et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: